This analysis highlights the strengths and limitations of BBBMs, demonstrating that while pTau181 and ApoE4 performed exceptionally well in discriminating AD from HC, the Aβ1-42/1-40 ratio exhibited some limitations and NfL emerged as a key marker in classifying CBS-Aβ(–), despite issues with sensitivity. The gene discussed is APOE; the disease is Alzheimer disease.